Pharmaceuticals

Pharma Grade Cellulose Powder Market Growth Patterns And Forecast Outlook Through 2030

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Pharma Grade Cellulose Powder Market From 2026 To 2030?

The pharma grade cellulose powder market size has observed substantial growth in recent years. This market is anticipated to expand from $1.55 billion in 2025 to $1.65 billion in 2026, at a compound annual growth rate (CAGR) of 6.1%. The expansion witnessed in the historical period is primarily due to an increase in oral drug formulations, the extensive utilization of cellulose excipients, the broadening of pharmaceutical manufacturing, the need for formulation stability, and the regulatory approval of cellulose-based excipients.

The market for pharma grade cellulose powder is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $2.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This projected growth is driven by several factors, including the increasing applications in nutraceuticals, a heightened demand for clean-label excipients, the expansion of generic drug development pipelines, innovations in excipient engineering, and evolving sustainability mandates. Key trends anticipated during this period encompass a growing preference for plant-based pharmaceutical excipients, greater utilization in solid oral dosage forms, wider adoption of microcrystalline cellulose, the development of multi-functional cellulose excipients, and an increased emphasis on sustainable sourcing of excipients.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24373&type=smp

Which Key Factors Are Driving The Pharma Grade Cellulose Powder Market Growth?

Increased pharmaceutical output is projected to boost the expansion of the pharma-grade cellulose powder market moving ahead. Pharmaceutical manufacturing entails the creation of medications through the formulation, synthesis, and quality control of both active components and inactive excipients, guaranteeing their safety, efficacy, and adherence to regulations. The growing prevalence of chronic conditions, necessitating ongoing and prolonged drug treatment for proper management, is driving an uptick in pharmaceutical production. Pharma-grade cellulose powder assists pharmaceutical manufacturing by serving as a reliable binding agent, filler, and stabilizing compound, which aids in preserving tablet structure and ensuring even distribution of active drugs. As an illustration, figures from June 2023, provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade group representing the European pharmaceutical sector, indicate that Europe’s total pharmaceutical output reached $422,803 million (€390,000 million) in 2023, showing an increase from $393,857 million (€363,300 million) in 2022. Consequently, the expansion in pharmaceutical production is fueling the growth of the pharma-grade cellulose powder market.

How Is Segmentation Applied In The Pharma Grade Cellulose Powder Market Segment Analysis?

The pharma grade cellulose powder market covered in this report is segmented –

1) By Product Type: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Hydroxypropyl Methylcellulose (HPMC), Hydroxypropyl Cellulose (HPC)

2) By Functionality: Binding Agent, Thickening Agent, Stabilizer, Disintegrant, Coating Agent

3) By Application: Pharmaceuticals, Nutraceuticals, Cosmetics, Other Applications

4) By End-User: Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic And Research Institutions, Manufacturers Of Dietary Supplements, Food And Beverage Industries

Subsegments:

1) By Microcrystalline Cellulose: Powder, Granules

2) By Carboxymethyl Cellulose (CMC): Sodium Carboxymethyl Cellulose (CMC), Calcium Carboxymethyl Cellulose (CMC), Other Carboxymethyl Cellulose (CMC) Variants

3) By Hydroxypropyl Methylcellulose (HPMC): Low Viscosity Hydroxypropyl Methylcellulose (HPMC), Medium Viscosity Hydroxypropyl Methylcellulose (HPMC), High Viscosity Hydroxypropyl Methylcellulose (HPMC)

4) By Hydroxypropyl Cellulose: Low Substitution Hydroxypropyl Cellulose (HPC), High Substitution Hydroxypropyl Cellulose (HPC)

Which Trends Are Guiding The Direction Of The Pharma Grade Cellulose Powder Market?

Major companies in the pharma-grade cellulose powder market are focusing on developing new microcrystalline cellulose facilities to expand production capacity and enhance their supply chain capabilities for pharmaceutical excipients. A microcrystalline cellulose facility is a specialized plant where purified cellulose undergoes controlled chemical and mechanical treatments to produce uniform, fine-grade particles for pharmaceutical use. For instance, in September 2023, Nitika Pharmaceuticals Specialties, an India-based excipient manufacturing company, inaugurated Tabcell, which is India’s largest microcrystalline cellulose (MCC) manufacturing plant, located at Nagpur. This plant, equipped with cutting-edge technology and an installed capacity of 1200 metric tons, was inaugurated by Union Minister Nitin Gadkari and marks a significant milestone under the Government of India’s Production Linked Incentive (PLI) scheme for excipients. This new plant strengthens Nitika Pharma’s position as a global leader in pharmaceutical excipients, supporting both domestic needs and exports to over 92 countries, while also contributing to the “Make in India” initiative and generating substantial local employment opportunities.

Who Are The Companies Participating In The Pharma Grade Cellulose Powder Market Environment?

Major companies operating in the pharma grade cellulose powder market are Roquette Frères, Ashland Global, JRS Pharma, DFE Pharma, Sigachi Industries Ltd., Accent Microcell Ltd., FMC Corporation, Dow Chemical Company, Shin-Etsu Chemical Co. Ltd., Colorcon, Nippon Paper Industries Co. Ltd., Rayonier Advanced Materials, Lotte Fine Chemical, Mingtai Chemical Co. Ltd., Weifang Lude Chemical Co. Ltd., Shandong Head Co. Ltd., Zhejiang Kehong Chemical Co. Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Maple Biotech Pvt. Ltd., Ankit Pulps & Boards Pvt. Ltd.

Get The Full Pharma Grade Cellulose Powder Market Report:

https://www.thebusinessresearchcompany.com/report/pharma-grade-cellulose-powder-global-market-report

Which Region Dominates The Pharma Grade Cellulose Powder Market By Market Share?

North America was the largest region in the pharma-grade cellulose powder market in 2025. The regions covered in the pharma grade cellulose powder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharma Grade Cellulose Powder Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharma-grade-cellulose-powder-global-market-report

Browse Through More Reports Similar to the Global Pharma Grade Cellulose Powder Market 2026, By The Business Research Company

Cellulose Gel Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-gel-global-market-report

Cellulose Acetate Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-acetate-global-market-report

Cellulose Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulose-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795